Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 74

Similar articles for PubMed (Select 17522716)

1.

Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition.

Verheul HM, Pinedo HM.

Nat Rev Cancer. 2007 Jun;7(6):475-85.

PMID:
17522716
2.

Cardiovascular and renal toxicity during angiogenesis inhibition: clinical and mechanistic aspects.

Kappers MH, van Esch JH, Sleijfer S, Danser AH, van den Meiracker AH.

J Hypertens. 2009 Dec;27(12):2297-309. doi: 10.1097/HJH.0b013e3283309b59. Review.

PMID:
19680138
3.

Antiangiogenic therapy in malignant glioma: promise and challenge.

Sathornsumetee S, Rich JN.

Curr Pharm Des. 2007;13(35):3545-58. Review.

PMID:
18220791
4.

Hypertension, proteinuria, and antagonism of vascular endothelial growth factor signaling: clinical toxicity, therapeutic target, or novel biomarker?

van Heeckeren WJ, Ortiz J, Cooney MM, Remick SC.

J Clin Oncol. 2007 Jul 20;25(21):2993-5. No abstract available.

5.

Pathways mediating resistance to vascular endothelial growth factor-targeted therapy.

Ellis LM, Hicklin DJ.

Clin Cancer Res. 2008 Oct 15;14(20):6371-5. doi: 10.1158/1078-0432.CCR-07-5287. Review.

6.

Molecular mechanisms and therapeutic development of angiogenesis inhibitors.

Cao Y.

Adv Cancer Res. 2008;100:113-31. doi: 10.1016/S0065-230X(08)00004-3. Review.

PMID:
18620094
7.
8.

Hypoxia inducible factor-1 independent pathways in tumor angiogenesis.

Mizukami Y, Kohgo Y, Chung DC.

Clin Cancer Res. 2007 Oct 1;13(19):5670-4. Review.

9.

Antiangiogenic therapy for metastatic breast cancer: current status and future directions.

Chan A.

Drugs. 2009;69(2):167-81. doi: 10.2165/00003495-200969020-00003. Review.

PMID:
19228074
10.

VEGF kinase inhibitors: how do they cause hypertension?

Bhargava P.

Am J Physiol Regul Integr Comp Physiol. 2009 Jul;297(1):R1-5. doi: 10.1152/ajpregu.90502.2008. Epub 2009 May 13. Review.

11.

Angiogenesis as a therapeutic target in malignant gliomas.

Chi AS, Sorensen AG, Jain RK, Batchelor TT.

Oncologist. 2009 Jun;14(6):621-36. doi: 10.1634/theoncologist.2008-0272. Epub 2009 Jun 1. Review.

12.

Complications from vascular disrupting agents and angiogenesis inhibitors: aberrant control of hemostasis and thrombosis.

van Heeckeren WJ, Sanborn SL, Narayan A, Cooney MM, McCrae KR, Schmaier AH, Remick SC.

Curr Opin Hematol. 2007 Sep;14(5):468-80. Review.

PMID:
17934353
13.

Management of hypertension in angiogenesis inhibitor-treated patients.

Izzedine H, Ederhy S, Goldwasser F, Soria JC, Milano G, Cohen A, Khayat D, Spano JP.

Ann Oncol. 2009 May;20(5):807-15. doi: 10.1093/annonc/mdn713. Epub 2009 Jan 15. Review.

14.

Biologic therapy of breast cancer: focus on co-inhibition of endocrine and angiogenesis pathways.

Roy V, Perez EA.

Breast Cancer Res Treat. 2009 Jul;116(1):31-8. doi: 10.1007/s10549-008-0268-y. Epub 2008 Dec 20. Review.

PMID:
19101790
15.

Hypertension and proteinuria: a class-effect of antiangiogenic therapies.

Launay-Vacher V, Deray G.

Anticancer Drugs. 2009 Jan;20(1):81-2. doi: 10.1097/CAD.0b013e3283161012.

PMID:
19343005
16.

Vascular endothelial growth factor pathway-targeted therapy as initial systemic treatment of patients with renal cancer.

Chung EK, Stadler WM.

Clin Genitourin Cancer. 2008 Dec;6 Suppl 1:S22-8. Review.

PMID:
19891126
17.

[Metronomic chemotherapy in pediatric oncology: hype or hope?].

André N, Pasquier E, Verschuur A, Sterba J, Gentet JC, Rössler J.

Arch Pediatr. 2009 Aug;16(8):1158-65. doi: 10.1016/j.arcped.2009.03.019. Epub 2009 May 14. Review. French.

PMID:
19446445
18.

Gastrointestinal toxicities of novel agents in cancer therapy.

Asnacios A, Naveau S, Perlemuter G.

Eur J Cancer. 2009 Sep;45 Suppl 1:332-42. doi: 10.1016/S0959-8049(09)70047-4. No abstract available.

PMID:
19775629
19.

Anti-vascular endothelial growth factor therapy for malignant glioma.

Gerstner ER, Sorensen AG, Jain RK, Batchelor TT.

Curr Neurol Neurosci Rep. 2009 May;9(3):254-62. Review.

PMID:
19348715
20.

Thrombosis associated with angiogenesis inhibitors.

Elice F, Rodeghiero F, Falanga A, Rickles FR.

Best Pract Res Clin Haematol. 2009 Mar;22(1):115-28. doi: 10.1016/j.beha.2009.01.001. Review.

PMID:
19285278
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk